ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

INDP Indaptus Therapeutics Inc

2,00
-0,005 (-0,25%)
Zuletzt aktualisiert: 17:03:48
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Indaptus Therapeutics Inc INDP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,005 -0,25% 2,00 17:03:48
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,02 2,00 2,1063 2,005
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
11.4.202413:30GLOBEIndaptus Therapeutics Presents Positive Mechanism of Action..
28.3.202413:00GLOBEIndaptus Therapeutics to Present at the MedInvest Biotech..
25.3.202413:30GLOBEIndaptus Therapeutics Previews Positive Mechanism of Action..
18.3.202413:00GLOBEIndaptus Therapeutics to Participate in Tribe Public Webinar..
13.3.202412:30GLOBEIndaptus Therapeutics Reports Fourth Quarter and Year-End..
04.3.202417:01EDGAR2Form 8-K - Current report
04.3.202413:30GLOBEIndaptus Therapeutics Announces Positive Results from Second..
15.2.202414:00GLOBEIndaptus Therapeutics to Present at the 2024 BIO CEO &..
08.2.202414:00GLOBEIndaptus Therapeutics Expands Digital Presence with Launch..
23.1.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:05EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEEuropean Patent Office Approves Key Patent for Indaptus..
06.11.202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06.11.202322:05EDGAR2Form 8-K - Current report
06.11.202322:01GLOBEIndaptus Therapeutics Reports Third Quarter 2023 Financial..
06.11.202314:13EDGAR2Form 8-K - Current report
06.11.202314:00GLOBEIndaptus Therapeutics’ Decoy20 Demonstrated a Broad Immune..
31.10.202314:12EDGAR2Form 8-K - Current report
31.10.202314:01GLOBEIndaptus Therapeutics to Present Positive Pharmacodynamic..
27.9.202314:00GLOBEIndaptus Therapeutics to Present at the LD Micro Main Event..
26.9.202314:00GLOBERegistration Is Now Open For Tribe Public’s Webinar Event..
19.9.202314:00GLOBEIndaptus Therapeutics Doses First Patient in Second Cohort..
06.9.202314:05GLOBEIndaptus Therapeutics to Present at the H.C. Wainwright 25th..
17.8.202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202314:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202314:10EDGAR2Form 8-K - Current report
14.8.202314:00GLOBEIndaptus Therapeutics Reports Second Quarter 2023 Financial..
10.8.202314:45EDGAR2Form 8-K - Current report
10.8.202314:45GLOBEIndaptus Therapeutics Announces Opening of Next Cohort in..
07.8.202314:00GLOBEIndaptus Therapeutics Appoints Industry Veteran Roger..
15.6.202314:00GLOBEIndaptus Therapeutics to Participate in the Maxim Group..
31.5.202314:30GLOBEIndaptus Therapeutics to Present at the Jefferies Healthcare..
11.5.202313:00GLOBEIndaptus Therapeutics Reports First Quarter 2023 Financial..
09.5.202314:00GLOBEFollowing Granting of Indian Patent, Indaptus Therapeutics..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock